The hallucinatory drug PCP (phencyclidine)
a. is an antagonist of the NMDA receptor.
b. facilitates the binding of glutamate to the AMPA receptor.
c. releases serotonin from neurons in the raphe nuclei.
d. inhibits the dendrites of dopamine neurons in the ventral tegmental area.
e. acts via the blockade of serotonin receptors.
Question 2
Which of the following is true of NMDA receptors?
a. Activation of the NMDA receptor allows sodium and calcium ions to flow into the nerve cell.
b. NMDA receptors are metabotropic.
c. NMDA receptors are the most common glutamate receptor.
d. The activity of the NMDA receptor is not dependent on magnesium ions.
e. The NMDA receptor produces IPSPs.
Subcutaneous drug administration: (a) cross section of skin showing depth of needle insertion;
Alzheimer’s Drugs Work by Intensifying the Effect of Acetylcholine at the Receptor
The approval of a new drug is a four-stage process: (1) preclinical investigation, (2) clinical inve
Effects of a Targeted Deletion of the μ Opiate Receptor
Frequency distribution curve: interpatient variability in drug response.
Clinically Significant Drug-Drug Interactions in Dentistry